The AI Infrastructure Layer for Institutional Biotech.
Palantir-grade infrastructure logic. NVIDIA-style architecture messaging. Built for pharma enterprises, CROs, academic medical centers, and government health agencies that require institutional security, regulatory alignment, and scientific precision — not SaaS features.
Built for Every Institutional Structure
Five deployment architectures — each designed for the unique procurement, compliance, and operational requirements of its institutional category.
Pharma Enterprise Licensing
Multi-site deployment with dedicated AI infrastructure, white-label configuration, and integrated Veeva/Salesforce data flows. Covers all commercialization functions from IND to post-approval market access.
CRO Infrastructure Partnerships
Infrastructure licensing that CROs deploy as a billable service layer for their biotech clients — enabling AI-assisted trial intelligence, site selection optimization, and automated scientific reporting.
Government & Public Health Deployment
Sovereign cloud-compatible deployment for government health agencies and defense biomedical programs. FedRAMP-aligned architecture with full data residency controls and classified-compatible integration pathways.
Clinical AI Infrastructure Integration
Embedded AI layer for clinical research units at academic medical centers and health systems — connecting trial intelligence, biomarker analysis, and regulatory documentation pipelines to existing EHR infrastructure.
Private Scientific Cloud Deployment
Fully isolated private cloud deployment for organizations with stringent data sovereignty requirements — biodefense contractors, rare disease companies handling sensitive patient cohorts, or Phase I trial units.
Custom Deployment Architecture
Don't see your institutional model? Our solutions team designs custom deployment architectures for unique organizational structures.
Institutional Engagement Models
Three deal structures designed for different organizational maturity levels and infrastructure investment horizons.
Full-platform deployment across multiple product lines or regions. Includes all five infrastructure layers, dedicated compliance configuration, custom model training, and quarterly infrastructure reviews.
Late-stage biotechs, emerging pharma, large CROs
Security Built for Institutional Procurement
Every security and compliance capability is designed to pass enterprise procurement reviews, institutional security audits, and regulatory due diligence processes out of the box.
Business Associate Agreement available
EU/EEA data residency controls
Audit in progress — Q3 2026
GCP, GMP, GLP alignment
Electronic records & signatures
GCP trial documentation standards
At-rest and in-transit
SAML 2.0 / OIDC / Okta / Azure AD
Zero cross-tenant data access
End-to-End Encryption
AES-256 at rest, TLS 1.3 in transit, zero-trust network architecture. No plaintext data at any layer of the stack.
Tenant Data Isolation
Complete logical and physical isolation between tenants. No shared storage, no cross-tenant queries, no shared inference context.
Immutable Audit Infrastructure
Cryptographically signed, append-only audit logs. Every AI decision, user action, and data access event recorded and tamper-proof.
Institutional Deployment Evidence
Four documented enterprise deployments across pharma, genomics, CRO, and clinical research — with full infrastructure context, regulatory impact, and measurable outcomes.
NovaTera Biosciences
Boston, MA · Phase II/III
A precision oncology company with three concurrent Phase II trials was spending 14 weeks per cycle manually synthesizing clinical data, generating investor updates, and managing regulatory documentation across FDA and EMA jurisdictions simultaneously.
Translational analysis pipelines ingested raw Phase II efficacy data from three trial sites, cross-referenced against biomarker signatures, and generated investor-grade interim analysis narratives automatically.
CIPHER engine configured for dual-jurisdiction (FDA/EMA) review. All 47 interim reports passed regulatory pre-screening without manual revision.
Enterprise Infrastructure Capabilities
Every enterprise capability is designed to meet institutional procurement standards — not consumer product requirements.
Dedicated Compute Clusters
Isolated tenant infrastructure with guaranteed resource allocation and SLA-backed uptime.
Custom Model Fine-Tuning
Domain-specific model training on your proprietary scientific data and therapeutic area.
White-Label Deployment
Full brand customization — domain, UI, email templates, and reporting formats.
SSO / SAML 2.0 / OIDC
Enterprise identity management via Okta, Azure AD, Ping Identity, or any SAML 2.0 provider.
Role-Based Access Control
Granular permissions by department, geography, therapeutic area, and data sensitivity level.
Full API + GraphQL Access
Build custom internal tools and integration pipelines on top of the AI commercialization engine.
Data Residency Controls
Choose EU, US, or APAC data centers. Air-gap and on-premise deployment available for sovereign requirements.
Dedicated Scientific CSM
Assigned Customer Success Manager with biotech domain expertise, weekly strategy reviews, and 4-hour engineering SLA.
Start Your Enterprise Infrastructure Conversation.
Our enterprise solutions team scopes your exact deployment requirements, maps your regulatory environment, and delivers a custom infrastructure deployment proposal within 48 hours — no commitment required.